Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.
Department of Cardiology, Duke Clinical Research Institute, Durham, North Carolina.
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.
This study aimed to examine the 30-day unplanned readmissions rate, predictors of readmission, causes of readmissions, and clinical impact of readmissions after percutaneous coronary intervention (PCI).
Unplanned rehospitalizations following PCI carry significant burden to both patients and the local health care economy and are increasingly considered as an indicator of quality of care.
Patients undergoing PCI between 2013 and 2014 in the U.S. Nationwide Readmission Database were included. Incidence, predictors, causes, and cost of 30-day unplanned readmissions were determined.
A total of 833,344 patients with PCI were included, of whom 77,982 (9.3%) had an unplanned readmission within 30 days. Length of stay for the index PCI was greater (4.7 vs. 3.9 days) and mean total hospital cost ($23,211 vs. $37,524) was higher for patients who were readmitted compared with those not readmitted. The factors strongly independently associated with readmissions were index hospitalization discharge against medical advice (odds ratio [OR]: 1.91; 95% confidence interval [CI]: 1.65 to 2.22), transfer to short-term hospital for inpatient care (OR: 1.62; 95% CI: 1.38 to 1.90), discharge to care home (OR: 1.57; 95% CI: 1.51 to 1.64), and chronic kidney disease (OR: 1.50; 95% CI: 1.44 to 1.55). Charlson Comorbidity Index score (OR: 1.28; 95% CI: 1.27 to 1.29) and number of comorbidities (OR: 1.18; 95% CI: 1.17 to 1.18) were independently associated with unplanned readmission. The majority of readmissions were due to noncardiac causes (56.1%).
Thirty-day readmissions after PCI are relatively common and relate to baseline comorbidities and place of discharge. More than one-half of the readmissions were due to noncardiac causes.
本研究旨在探讨经皮冠状动脉介入治疗(PCI)后 30 天非计划性再入院率、再入院的预测因素、再入院的原因以及再入院的临床影响。
PCI 后非计划性再住院给患者和当地医疗保健经济带来了巨大负担,并且越来越被认为是医疗质量的一个指标。
纳入美国全国再入院数据库中 2013 年至 2014 年接受 PCI 的患者。确定 30 天内非计划性再入院的发生率、预测因素、原因和成本。
共纳入 833344 例接受 PCI 的患者,其中 77982 例(9.3%)在 30 天内发生非计划性再入院。与未再入院的患者相比,再入院患者的住院时间更长(4.7 天 vs. 3.9 天),总住院费用更高(23211 美元 vs. 37524 美元)。与再入院显著相关的因素包括:指数住院期间出院时医嘱不遵从(优势比[OR]:1.91;95%置信区间[CI]:1.65 至 2.22)、转至短期医院接受住院治疗(OR:1.62;95% CI:1.38 至 1.90)、转至护理院(OR:1.57;95% CI:1.51 至 1.64)和慢性肾脏病(OR:1.50;95% CI:1.44 至 1.55)。Charlson 合并症指数评分(OR:1.28;95% CI:1.27 至 1.29)和合并症数量(OR:1.18;95% CI:1.17 至 1.18)与非计划性再入院独立相关。大多数再入院是由于非心脏原因(56.1%)。
PCI 后 30 天再入院较为常见,与基线合并症和出院地点有关。超过一半的再入院是由于非心脏原因。